Novo Nordisk reported great first quarter results again but free cash flow declined - in part due to high capital expenditures. At this point, we can expect the obesity market to continue growing ...
The vast majority of patients using GLP-1 agonists such as Ozempic and Wegovy are being treated for diabetes or chronic weight management. GLP-1 medications are believed to have further ...
Novo Nordisk A/S said it retains about 60% of the list price of Ozempic and Wegovy in the US after rebates and fees paid to middlemen, as the debate heats up over the cost of its blockbuster ...
Novo Nordisk (NVO) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Novo Nordisk has filed nine lawsuits against medical spas, wellness clinics and pharmacies for allegedly selling impure products claiming to contain semaglutide, the active ingredient in its ...
Novo Nordisk A/S has a greater impact on Denmark’s employment levels than previously estimated, according to the state’s fiscal watchdog, aggravating concerns the Nordic economy is becoming ...
Eli Lilly and Novo Nordisk have generated incredible returns for investors in the past few years. The surging popularity of their weight loss treatments has produced a lot of bullishness.
, opens new tab said on Thursday it had sued nine more medical spas, wellness clinics and pharmacies in the U.S. for selling products claiming to contain semaglutide, the key ingredient in its ...
Novo Nordisk is contesting Sen. Bernie Sanders' calls to reduce the list prices of Ozempic and Wegovy in the U.S., Bloomberg reports. In late April, the Senate Health, Education, Labor, and ...
The manufacturer of Ozempic and Wegovy filed nine additional lawsuits against businesses in six states that allegedly sold unapproved compounded versions of the popular drugs. In total, Denmark ...
Over the last few years, some of the best-performing stocks in the broader healthcare space have been pharmaceutical businesses. A big reason for this is the rise in popularity of weight loss ...